You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DS1000

Showing 1 - 25 of 402
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mitral Regurgitation, Mitral Valve Disease, Mitral Valve Insufficiency Trial in Germany, Greece, Switzerland (NeoChord

Recruiting
  • Mitral Regurgitation
  • +4 more
  • NeoChord Artificial Chordae Delivery System, Model DS1000
  • Bonn, Germany
  • +4 more
Jul 9, 2020

Cardiovascular Diseases Trial in Bron (NeoChord beating heart mitral valve implantation, Control)

Withdrawn
  • Cardiovascular Diseases
  • NeoChord beating heart mitral valve implantation
  • Control
  • Bron, France
    Hôpital Louis Pradel
Jan 8, 2020

Hidradenitis Suppurativa Trial in Canada, Poland, United States (Izokibep, Placebo to izokibep)

Recruiting
  • Hidradenitis Suppurativa
  • Encino, California
  • +51 more
Feb 1, 2023

Mitral Valve Insufficiency Trial in United States (NeoChord DS1000, Surgical Mitral Valve Repair)

Recruiting
  • Mitral Valve Insufficiency
  • NeoChord DS1000
  • Surgical Mitral Valve Repair
  • Oakland, California
  • +17 more
Dec 4, 2019

Netherton Syndrome Trial in Paris (DS-2325a, Placebo)

Not yet recruiting
  • Netherton Syndrome
  • Paris, France
    Saint Louis Hospital
Jul 31, 2023

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (T-DXd), Ado-trastuzumab emtansine (T-DM1))

Active, not recruiting
Has Results
  • Breast Cancer
  • Trastuzumab deruxtecan (T-DXd)
  • Ado-trastuzumab emtansine (T-DM1)
  • Los Angeles, California
  • +163 more
Apr 1, 2022

Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan (DS-8201a), Capecitabine, Eribulin)

Active, not recruiting
  • Breast Cancer
  • Trastuzumab deruxtecan (DS-8201a)
  • +5 more
  • Chandler, Arizona
  • +207 more
Jan 25, 2022

Lupus or SLE, Nephritis Trial in Assiut (Baricitinib 4 MG, Baricitinib 2 MG, MMF)

Recruiting
  • Lupus or SLE
  • Nephritis
  • Baricitinib 4 MG
  • +2 more
  • Assiut, Yes, Egypt
    Manal Hassanien
Jan 13, 2023

Guillain-Barré Syndrome Trial (Crovalimab, Placebo, Intravenous immunoglobulin therapy)

Not yet recruiting
  • Guillain-Barré Syndrome
  • (no location specified)
Aug 8, 2022

Overweight and Obesity Trial in Glasgow (ß-glucan, Placebo)

Recruiting
  • Overweight and Obesity
  • β-glucan
  • Placebo
  • Glasgow, United Kingdom
    University of Glasgow
Jul 31, 2023

Mitral Valve Insufficiency, Mitral Regurgitation Trial (Chordal tension measurement, Cardiac Magnetic Resonance Imaging (MRI))

Withdrawn
  • Mitral Valve Insufficiency
  • Mitral Regurgitation
  • Chordal tension measurement
  • Cardiac Magnetic Resonance Imaging (MRI)
  • (no location specified)
Mar 9, 2022

Daytime Surgery in Varicose Veins and Without Superficial Venous

Not yet recruiting
  • Varicose Veins
  • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Memorial Hospital, Sun Yat-sen University
    May 17, 2022

    Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

    Active, not recruiting
    • Non Hodgkin Lymphoma
    • Birmingham, Alabama
    • +19 more
    Dec 8, 2022

    Activation of Primordial Follicles Trial in Ankara (Ovarian puncture)

    Recruiting
    • Activation of Primordial Follicles
    • Ovarian puncture
    • Ankara, Turkey
      Hacettepe UniversityHacettepe University School of Medicine, Dep
    Sep 18, 2022

    Cancer Trial in New Orleans, Allentown

    Recruiting
    • Cancer
      • New Orleans, Louisiana
      • +1 more
      Oct 14, 2022

      Gastroesophageal Junction (GEJ) Adenocarcinoma Trial in Beijing (Q-1802 Injection,Oxaliplatin Injection,Capecitabine)

      Recruiting
      • Gastroesophageal Junction (GEJ) Adenocarcinoma
      • Q-1802 Injection,Oxaliplatin Injection,Capecitabine
      • Beijing, Beijing, China
        Beijing cancer hospical
      Jul 27, 2023

      Pregnancy, Labor Pain Trial in Chicago (Routine oxytocin, Half-dose oxytocin)

      Completed
      • Pregnancy
      • Labor Pain
      • Routine oxytocin
      • Half-dose oxytocin
      • Chicago, Illinois
        Prentice Women's Hospital
      Feb 11, 2022

      Study of New Magnetic Resonance Imaging Methods of the Brain

      Recruiting
      • Healthy
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 2, 2023

        Vitiligo Trial in Worcester (Metformin Hydrochloride)

        Not yet recruiting
        • Vitiligo
        • Metformin Hydrochloride
        • Worcester, Massachusetts
          UMass Chan Medical School
        Nov 6, 2022

        Atrial Fibrillation, Anticoagulants and Bleeding Disorders Trial in Netherlands (Left atrial appendage occlusion (Watchman FLX

        Recruiting
        • Atrial Fibrillation
        • Anticoagulants and Bleeding Disorders
        • Left atrial appendage occlusion (Watchman FLX or Amplatzer Amulet)
        • Leeuwarden, Friesland, Netherlands
        • +13 more
        Dec 19, 2022

        RUBY Post-Market Registry on the Jada® System

        Completed
        • Postpartum Hemorrhage
        • Jada® System
        • Loma Linda, California
        • +15 more
        Aug 18, 2022

        Stroke, Upper Extremity Paresis Trial in Pittsburgh (Combined Non-invasive brain stimulation and functional electrical hand

        Recruiting
        • Stroke
        • Upper Extremity Paresis
        • Combined Non-invasive brain stimulation and functional electrical hand stimulation
        • Pittsburgh, Pennsylvania
          Neuromotor Recovery and Rehabilitation Lab
        Aug 1, 2022

        Hypertriglyceridemia, Type 2 Diabetes Trial in Worldwide (DS102, Placebo)

        Recruiting
        • Hypertriglyceridemia
        • Type 2 Diabetes
        • Albany, New York
        • +26 more
        Sep 7, 2021

        Latent Structure of Multi-level Assessments and Predictors of

        Active, not recruiting
        • Depression
        • +4 more
        • Women in a court diversion program
        • (no location specified)
        Apr 4, 2022

        Systemic Lupus Erythematosus, Pulmonary Arterial Hypertension Trial in Beijing (Rituximab)

        Not yet recruiting
        • Systemic Lupus Erythematosus
        • Pulmonary Arterial Hypertension
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Apr 13, 2023